Campbell et al., Simon F., “2,4-Diamino-6,7-dimethoxyquinazolines. 3. 2-(4-Heterocyclylpiperasin-1-yl) Derivatives as α1-Adrenoceptor Antagonists and Antihypertensive Agents”, J. Med. Chem., vol. 30, pp. 1794-1798, 1987. |
Dourish, Colin T., “Multiple Serotonin Receptors: Opportunities for New Treatments for Obesity?”, Obesity Research, vol. 3, Suppl. 4, pp. 449S-462S, 1995. |
Dukat et al., Malgorzata, “Structure-Activity Relationships fo rthe Binding of Arylpiperazines and Arylbiguanides at 5-HT3 Serotonin Receptors”, J. Med. Chem., vol. 39, pp. 4017-4026, 1996. |
Jenck et al., F., “The role of 5-HT2c receptors in affective disorders”, Exp. Opin. Invest. Drugs, pp. 1587-1599, 1998. |
Kennett, GA, “5-HT drugs and eating disorders”, IDrugs, vol. 1, No. 4, pp. 456-470, 1998. |
Lee et al., Hong Shick, “Effect of the Serontonin Agonist, MK-212, on the Body Temperature in Schizophrenia”, Society of Biological Phychiatry, vol. 31, pp. 460-470, 1992. |
Leysen, Dirk C.M., “Selective 5-HT2c agonists as potential antidepressants”, IDrugs, vol. 2(2), pp. 109-120, 1999. |
Lumma et al., Jr., William C., “Piperazinylpyrazines with Central Serotoninmimetic Activity”, Journal of Medicinal Chemistry, vol. 21, No. 6, pp. 536-542, 1978. |
Lumma, Jr. et al., William C., “Piperazinylquinoxalines with Central Serotoninmimetic Activity”, J. Med. Chem., vol. 24, pp. 93-101, 1981. |
Meltzer, Herbert Y., “Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia”, Psychopharmacology, pp. S18-S27, 1989. |
Methvin et al., Isaac, “Pyrrolo[3,2,2-ij] quinoline Derivatives, a 5-HT2c Receptor Agonist with Selectivity over the 5-HT2a Receptor: Potential Therapeutic Applications for Epilepsy and Obesity”, Biiorganic & Medicinal Chemistry Letters, vol. 10, pp. 919-921, 2000. |
Pavia et al., Michael R., “6-Alkyl-N, N-disubstrituted-2-pyridinamines as Anticonvulsant Agents”, J. Med. Chem., vol. 30., pp. 1210-1214, 1987. |
Pavia et al., Michael R., “6-Alkoxy-N, N-disubstrituted-2-pyridinamines as Anticonvulsant Agents”, J. Med. Chem., vol. 32, pp. 1237-1242, 1989. |
Rogers et al., R.J. , “Differential Effects of Novel Ligands for 5-HT Receptor Subtypes on Nonopioid Defensive Analgesia in Male Mice”, Neuroscience & Biobehavioral Reviews, vol. 15, pp. 489-495, 1991. |
Roth et al., Bryan L., “The Multiplicity of Serontonin Receptors: Uselessly Diverse Molecules or an Embarrassment of Riches?”, The Neuroscientist, pp. 252-262, 2000. |
Sargent et al., P.A., “5-HT2c receptor activation decreases appetite and body weight in obese subjects”, Psychopharmacology, vol. 133, pp. 309-312, 1997. |
Shutske et al., Gregory M., “Synthesis of Some Piperazinylpyrazolo[3,4-b]pyridines as Selective Serotonin Re-uptake Inhibitors”, J. Heterocylic Chem., vol. 34, pp. 789-795, 1997. |
Tecott et al., Laurence H., “Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors”, Nature, vol. 374, pp. 542-546, 1995. |